Liu Fang-Yuan, Ding Dan-Ni, Wang Yun-Rui, Liu Shao-Xuan, Peng Cheng, Shen Fang, Zhu Xiao-Ya, Li Chan, Tang Li-Ping, Han Feng-Juan
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Front Pharmacol. 2023 Jun 30;14:1216363. doi: 10.3389/fphar.2023.1216363. eCollection 2023.
Numerous chemical compounds used in cancer treatment have been isolated from natural herbs to address the ever-increasing cancer incidence worldwide. Therein is icariin, which has been extensively studied for its therapeutic potential due to its anti-inflammatory, antioxidant, antidepressant, and aphrodisiac properties. However, there is a lack of comprehensive and detailed review of studies on icariin in cancer treatment. Given this, this study reviews and examines the relevant literature on the chemopreventive and therapeutic potentials of icariin in cancer treatment and describes its mechanism of action. The review shows that icariin has the property of inhibiting cancer progression and reversing drug resistance. Therefore, icariin may be a valuable potential agent for the prevention and treatment of various cancers due to its natural origin, safety, and low cost compared to conventional anticancer drugs, while further research on this natural agent is needed.
许多用于癌症治疗的化合物已从天然草药中分离出来,以应对全球范围内不断上升的癌症发病率。其中就有淫羊藿苷,由于其具有抗炎、抗氧化、抗抑郁和壮阳特性,人们对其治疗潜力进行了广泛研究。然而,目前缺乏对淫羊藿苷在癌症治疗方面研究的全面而详细的综述。鉴于此,本研究回顾并审视了关于淫羊藿苷在癌症治疗中的化学预防和治疗潜力的相关文献,并描述了其作用机制。该综述表明,淫羊藿苷具有抑制癌症进展和逆转耐药性的特性。因此,与传统抗癌药物相比,淫羊藿苷因其天然来源、安全性和低成本,可能是预防和治疗各种癌症的有价值的潜在药物,不过仍需要对这种天然药物进行进一步研究。